Pharmacy based dosing of darbepoetin in haemodialysis patients of the Sint Franciscus Gasthuis

Completed

• Conditions: anaemia; end stage renal disease; 10038430

• Registration Number: NL-OMON33197
• Lead Sponsor: Sint Franciscus Gasthuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-04-17
• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

All haemodialysis patients treated with darbepoetin

Exclusion Criteria

Patients with less than three prospective haemoglobin values included in data analysis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Which percentage of haemodialysis patients reaches haemoglobin values within<br /><br>the target range (6.8-7.4 mmol/l) with darbepoetin dosage defined by<br /><br>nephrologist alone compared with dosage defined by pharmacist and nephrologist?</p><br>